mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.006 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.007 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.008 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.008 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.008 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.008 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.009 |